Zobrazeno 1 - 9
of 9
pro vyhledávání: '"BACS, Brief Assessment of Cognition in Schizophrenia"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
NeuroImage : Clinical
NeuroImage: Clinical, Vol 32, Iss, Pp 102855-(2021)
NeuroImage: Clinical, Vol 32, Iss, Pp 102855-(2021)
Highlights • Patients are impaired regarding both, cognitive flexibility and stability. • Deficient prediction error discrimination is related to reduced striatal activation. • Decreased ACC and hippocampus activation predicts impaired rule swi
Autor:
Haddad, Chadia, Salameh, Pascale, Hallit, Souheil, Sacre, Hala, Clément, Jean-Pierre, Calvet, Benjamin
Publikováno v:
Schizophrenia Research: Cognition
Schizophrenia Research: Cognition, Vol 26, Iss, Pp 100207-(2021)
Schizophrenia Research: Cognition, Elsevier, 2021, 26, pp.100207. ⟨10.1016/j.scog.2021.100207⟩
Schizophrenia Research: Cognition, Vol 26, Iss, Pp 100207-(2021)
Schizophrenia Research: Cognition, Elsevier, 2021, 26, pp.100207. ⟨10.1016/j.scog.2021.100207⟩
Objective The primary objective was to evaluate social cognitive complaints in a sample of chronic in-patients with schizophrenia and compare it to healthy controls. The secondary objective was to explore factors related to social cognitive complaint
Autor:
Jurjen J. Luykx, Angelique J. Goverde, Iris E. C. Sommer, Sophie M. Heringa, Sebastianus B.J. Oude Ophuis, P. Roberto Bakker, Bieke De Wilde, Kirsten C.E.E.R. Catthoor, Bodyl A Brand, Machteld Marcelis, Margot I. E. Slot, Thomas W. Weickert, Janna de Boer, Koen P. Grootens, Cynthia Shannon Weickert
Publikováno v:
Contemporary Clinical Trials Communications, 20:100681. HANLEY & BELFUS-ELSEVIER INC
Contemporary Clinical Trials Communications, Vol 20, Iss, Pp 100681-(2020)
Contemporary Clinical Trials Communications, 20:100681. Elsevier Inc.
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 20, Iss, Pp 100681-(2020)
Contemporary Clinical Trials Communications, 20:100681. Elsevier Inc.
Contemporary Clinical Trials Communications
Although acute psychotic symptoms are often reduced by antipsychotic treatment, many patients with schizophrenia are impaired in daily functioning due to the persistence of negative and cognitive symptoms. Raloxifene, a Selective Estrogen Receptor Mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db84836502b0013c4eaa0a5901bf3e0
https://research.rug.nl/en/publications/2161c306-46c6-4ef3-8b97-71f95e78fd2d
https://research.rug.nl/en/publications/2161c306-46c6-4ef3-8b97-71f95e78fd2d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daiki Sasabayashi, Yuko Higuchi, Haruko Kobayashi, Yoichiro Takayanagi, Atsushi Furuichi, Kyo Noguchi, Shimako Nishiyama, Michio Suzuki, Tien Viet Pham, Tsutomu Takahashi, Yukiko Akasaki, Yuko Mizukami
Publikováno v:
NeuroImage : Clinical
NeuroImage: Clinical, Vol 32, Iss, Pp 102805-(2021)
NeuroImage: Clinical, Vol 32, Iss, Pp 102805-(2021)
Highlights • Pineal morphology was investigated in schizophrenia patients and ARMS subjects. • Pineal volumes were significantly smaller in both groups than in healthy controls. • Pineal cysts were associated with clinical symptomatology in sch
Autor:
Tsutomu Takahashi, Shimako Nishiyama, Yuko Komori, Michio Suzuki, Yuko Higuchi, Tomiki Sumiyoshi, Motomu Suga, Kiyoto Kasai, Tomonori Seo
Publikováno v:
Schizophrenia Research: Cognition
Schizophrenia Research: Cognition, Vol 7, Iss C, Pp 13-18 (2017)
Schizophrenia Research: Cognition, Vol 7, Iss C, Pp 13-18 (2017)
Cognitive function is impaired in patients with schizophrenia-spectrum disorders, even in their prodromal stages. Specifically, the assessment of cognitive abilities related to daily-living functioning, or functional capacity, is important to predict
Autor:
Brand BA; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht, the Netherlands.; Department of Biomedical Sciences and Systems, Cognitive Neurosciences, University of Groningen, University Medical Center Groningen (UMCG), Groningen, the Netherlands., de Boer JN; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht, the Netherlands.; Department of Biomedical Sciences and Systems, Cognitive Neurosciences, University of Groningen, University Medical Center Groningen (UMCG), Groningen, the Netherlands., Oude Ophuis SBJ; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht, the Netherlands., Slot MIE; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht, the Netherlands., De Wilde B; Ziekenhuis Netwerk Antwerpen (ZNA), Antwerp, Belgium., Catthoor KCEER; Ziekenhuis Netwerk Antwerpen (ZNA), Antwerp, Belgium.; The Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp, Belgium., Goverde AJ; Department of Reproductive Medicine and Gynaecology, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands., Bakker PR; Arkin, Institute for Mental Health, Amsterdam, the Netherlands.; Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands., Marcelis MC; Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.; Institute for Mental Health Care Eindhoven (GGzE), Eindhoven, the Netherlands., Grootens KP; Reinier van Arkel Institute for Mental Health Care (RvA), 's Hertogenbosch, the Netherlands., Luykx JJ; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht, the Netherlands.; Ziekenhuis Netwerk Antwerpen (ZNA), Antwerp, Belgium.; Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center, Utrecht, Utrecht University, Utrecht, the Netherlands.; Outpatient Second Opinion Clinic, GGNet Mental Health, Warnsveld, the Netherlands., Heringa SM; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht, the Netherlands.; Isala, Department of Medical Psychology, Zwolle, the Netherlands., Weickert CS; Neuroscience Research Australia, Randwick, New South Wales, Australia.; State University of New York, Upstate Medical University, Syracuse, NY, USA., Sommer IEC; Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht (UMCU), Utrecht University, Utrecht, the Netherlands.; Department of Biomedical Sciences and Systems, Cognitive Neurosciences, University of Groningen, University Medical Center Groningen (UMCG), Groningen, the Netherlands., Weickert TW; Neuroscience Research Australia, Randwick, New South Wales, Australia.; State University of New York, Upstate Medical University, Syracuse, NY, USA.
Publikováno v:
Contemporary clinical trials communications [Contemp Clin Trials Commun] 2020 Nov 25; Vol. 20, pp. 100681. Date of Electronic Publication: 2020 Nov 25 (Print Publication: 2020).
Autor:
Higuchi Y; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Sumiyoshi T; Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Japan., Seo T; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Suga M; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Japan.; Department of Rehabilitation, The University of Tokyo Hospital, Japan., Takahashi T; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Nishiyama S; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Komori Y; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Kasai K; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Japan., Suzuki M; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan.
Publikováno v:
Schizophrenia research. Cognition [Schizophr Res Cogn] 2017 Feb 22; Vol. 7, pp. 13-18. Date of Electronic Publication: 2017 Feb 22 (Print Publication: 2017).